Cargando…

Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus

Background. Serum concentrations of soluble interleukin-7 receptor (sIL-7R) and anti-C1q antibody have recently been identified as unique serological markers for lupus nephritis (LN) in patients with systemic lupus erythematosus (SLE). In this study, we evaluated the correlation of serum sIL-7R and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Shuhong, Xue, Jing, Li, Feng, Zhu, Caixia, Yu, Yunxia, Li, Haibo, Wang, Xuemei, Zhang, Yurong, Yang, Jijuan, Zhou, Shaolan, Yang, Lijuan, Ji, Chen, Liu, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812203/ https://www.ncbi.nlm.nih.gov/pubmed/27069677 http://dx.doi.org/10.1155/2016/8252605

Ejemplares similares

Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis
por: Chi, Shuhong, et al.
Publicado: (2015)

Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis
por: Xue, Jing, et al.
Publicado: (2017)

Upregulation of microRNA‐762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus
por: Yang, Jijuan, et al.
Publicado: (2022)

Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus
por: Almutairi, Nora, et al.
Publicado: (2020)

Clinical associations of serum interleukin-17 in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2013)

Increased concentration of serum soluble LAG3 in systemic lupus erythematosus
por: Yu, Seri, et al.
Publicado: (2012)

Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
por: Wang, Hongxu, et al.
Publicado: (2016)

Decreased serum level of soluble-leptin-receptor in patients with systemic lupus erythematosus
por: Bagheri, K, et al.
Publicado: (2012)

Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
por: Rezaieyazdi, Zahra, et al.
Publicado: (2021)

Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity
por: Xie, Huan Huan, et al.
Publicado: (2018)

Mechanisms of Autoantibody Production in Systemic Lupus Erythematosus
por: Han, Shuhong, et al.
Publicado: (2015)

Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus
por: de Oliveira Peliçari, Karina, et al.
Publicado: (2015)

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
por: Mende, Rachel, et al.
Publicado: (2018)

Correlation of plasma and urine Wnt5A with the disease activity and cutaneous lesion severity in patients with systemic lupus erythematosus
por: Chi, Shuhong, et al.
Publicado: (2021)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Tim-1 alleviates lupus nephritis-induced podocyte injury via regulating autophagy
por: Yu, Yunxia, et al.
Publicado: (2021)

Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus
por: HASSAN, Waleed, et al.
Publicado: (2020)

Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease
por: Fischer, Katarzyna, et al.
Publicado: (2017)

Serum and Urinary Interleukin-6 in Assessment of Renal Activity in Egyptian Patients with Systemic Lupus Erythematosus
por: EL-Shereef, Rawhya R., et al.
Publicado: (2016)

Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus
por: Jin, Lairun, et al.
Publicado: (2018)

Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus
por: Brilland, Benoit, et al.
Publicado: (2021)

Hypomethylation of interleukin 6 correlates with renal involvement in systemic lupus erythematosus
por: Tang, Chun, et al.
Publicado: (2014)

The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus—A Pilot Study
por: Király, Zsófia, et al.
Publicado: (2023)

Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
por: Nakano, Miki, et al.
Publicado: (2021)

Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus
por: Pawlak-Buś, Katarzyna, et al.
Publicado: (2021)

Systemic lupus erythematosus following human papillomavirus 9-valent vaccination
por: Wan, Yuehua, et al.
Publicado: (2022)

Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis
por: Ding, Jianwen, et al.
Publicado: (2020)

Low-dose interleukin-2 therapy in systemic lupus erythematosus
por: La Cava, Antonio
Publicado: (2023)

Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus
por: Pan, Qingjun, et al.
Publicado: (2017)

Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus
por: Zhang, Qiong, et al.
Publicado: (2019)

C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus
por: van Schaarenburg, Rosanne A., et al.
Publicado: (2016)

IL-1 family cytokines and soluble receptors in systemic lupus erythematosus
por: Italiani, Paola, et al.
Publicado: (2018)

Serum Midkine Levels in Systemic Lupus Erythematosus
por: Marpaung, Blondina, et al.
Publicado: (2018)

Serum pentosidine levels in systemic lupus erythematosus
por: Nisihara, Renato, et al.
Publicado: (2020)

Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus
por: Shao, Miao, et al.
Publicado: (2018)

Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?
por: Dantas, Andréa Tavares, et al.
Publicado: (2015)

Interleukin-21: A New Mediator of Inflammation in Systemic Lupus Erythematosus
por: Sarra, Massimiliano, et al.
Publicado: (2010)

T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
por: Mak, Anselm
Publicado: (2022)

Detection of epitopes in systemic lupus erythematosus using peptide microarray
por: Li, Xin, et al.
Publicado: (2018)

miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus
por: Zhou, Shaolan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_396ps9s4g7mfl7g8pbr4d09s4e